he emergence of azole-resistance. This clinical reality creates an urgency for new antifungal drugs currently in advanced clinical development with more promising pharmacokinetic and pharmacodynamic profiles.

1. Introduction
Invasive fungal infections caused by various fungal genera, including Aspergillus, complicate and endanger lives of mill